Stoke Therapeutics Inc (STOK) — Capital Reinvestment Ratio

Latest as of March 2025: 0.00x

Stoke Therapeutics Inc (STOK) has a Capital Reinvestment Ratio of 0.00x as of March 2025, meaning it reinvests 0% of its operating cash flow ($131.83 Million) in capital expenditures ($152.00K). See STOK equity to assets ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$131.83 Million

USD

Capital Expenditures

$152.00K

USD

Data as of

Mar 2025

Most recent filing

Stoke Therapeutics Inc Capital Reinvestment Ratio (2025–2025)

This chart tracks Stoke Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Check total reinvestment intensity of Stoke Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Stoke Therapeutics Inc (2025–2025)

Year-by-year Capital Reinvestment Ratio for Stoke Therapeutics Inc from 2025 to 2025. For live market cap and broader valuation context, see market cap of Stoke Therapeutics Inc.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change
2025	0.01x	$45.59 Million	$670.00K	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow